In breast cancer models, CHD1L transcriptionally upregulates MDM2, as shown by cDNA microarray analysis and confirmed via Western blot, where CHD1L overexpression increased MDM2 protein levels, and CHD1L knockdown reduced them [73]. This evidence concerns the gene CHD1L and breast carcinoma.